SEC Form 4 · accession 0001209191-15-049853
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie Yu
Officer — VP Clinical Ops & Data Mgmt
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 7:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $12.28 | Jun 1, 2015 | A | 45,000 | A | — | Jun 1, 2025 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F1These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on June 1, 2016. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on July 1, 2016, with the final installment vesting on June 1, 2019.